Wolverine Trading’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-42,600
Closed -$1.26M 5507
2023
Q4
$1.26M Buy
+42,600
New +$848K ﹤0.01% 2070
2023
Q2
Sell
-22,800
Closed -$85K 5171
2023
Q1
$85K Buy
+22,800
New +$97.2K ﹤0.01% 3705
2022
Q4
Sell
-14,100
Closed -$66K 5321
2022
Q3
$66K Buy
+14,100
New +$74.3K ﹤0.01% 4064
2021
Q4
Sell
-24,800
Closed -$140K 7121
2021
Q3
$140K Sell
24,800
-2,200
-8% -$12.7K ﹤0.01% 5596
2021
Q2
$177K Buy
+27,000
New +$188K ﹤0.01% 5098
2020
Q4
Sell
-17,300
Closed -$62K 5634
2020
Q3
$62K Buy
17,300
+3,900
+29% +$15.7K ﹤0.01% 4243
2020
Q2
$59K Sell
13,400
-2,000
-13% -$8.51K ﹤0.01% 4279
2020
Q1
$55K Sell
15,400
-8,100
-34% -$35.4K ﹤0.01% 4228
2019
Q4
$119K Buy
23,500
+12,100
+106% +$41.1K ﹤0.01% 4235
2019
Q3
$31K Buy
+11,400
New +$30.3K ﹤0.01% 4126
2019
Q2
Sell
-66,700
Closed -$181K 5293
2019
Q1
$181K Buy
66,700
+11,800
+21% +$51.1K ﹤0.01% 3898
2018
Q4
$247K Buy
54,900
+25,500
+87% +$155K ﹤0.01% 3435
2018
Q3
$278K Buy
+29,400
New +$283K ﹤0.01% 3832
2018
Q1
Sell
-28,400
Closed -$182K 6013
2017
Q4
$182K Sell
28,400
-26,100
-48% -$161K ﹤0.01% 4217
2017
Q3
$417K Buy
54,500
+9,100
+20% +$60.5K ﹤0.01% 2827
2017
Q2
$328K Buy
+45,400
New +$208K ﹤0.01% 2916
2016
Q4
Sell
-48,100
Closed -$127K 5333
2016
Q3
$127K Buy
48,100
+19,000
+65% +$55.3K ﹤0.01% 4089
2016
Q2
$91K Buy
+29,100
New +$182K ﹤0.01% 3663

Other funds holding IMGN

Wolverine Trading's IMGN Position: Q1 2024 in Review

Wolverine Trading sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 9,166 shares — an estimated $272K sold.

Wolverine Trading first reported a position in IMGN in Q2 2017 and held it in 12 quarters. The position peaked at $398K in Q3 2017. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Wolverine Trading reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Wolverine Trading sold 9,166 Immunogen Inc shares in Q1 2024, an estimated $272K.
  • Wolverine Trading first reported a position in Immunogen Inc in Q2 2017 and held it in 12 quarters.
  • Wolverine Trading's Immunogen Inc position peaked at $398K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Wolverine Trading's 13F filing for Q1 2024, filed 15 May 2024.